PEPFAR Release September 4, 2025 Today, the U.S. Department of State announced a market-shaping initiative by the President’s Emergency Plan for AIDS Relief (PEPFAR) to bring U.S.-based Gilead Sciences’ breakthrough drug lenacapavir to market in high-burden HIV countries. The initiative – which will promote global scale in production and distribution of the medication and catalyze further global investment – has …
Read More »PEPFAR’s Support of American Innovation to Reach up to 2 Million People by 2028 with Breakthrough HIV Drug Lenacapavir
